Skip to main content
. Author manuscript; available in PMC: 2009 Mar 29.
Published in final edited form as: Anal Chem. 2007 Sep 29;79(21):8249–8256. doi: 10.1021/ac0706731

Figure 4.

Figure 4

Results for oligomerization inhibition study represented as (a) percent of total protein peak area determined by integration of best fit data, and (b) percent change for respective mixture component peak areas normalized to an experimental control versus pyridoxal 5-phosphate concentration. Oligomeric mixture components are denoted as monomeric, I (●); dimeric, II (◆); trimeric, III (▲); and tetrameric, IV (□); respectively. The total of aggregates (■) is obtained by taking the sum of the respective contributions of mixture components II–IV.